ARTIVA BIOTHERAPEUTICS INC (ARTV) Stock Cash Flow
NASDAQ:ARTV - Nasdaq - US04317A1079 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -71.72M | -65.37M | -28.72M | -58.79M | -71.83M | |||
| Depreciation Amortization | 2.47M | 2.43M | 2.27M | 1.16M | 248.00K | |||
| Change In Working Capital | 1.20M | -325.00K | -28.28M | -3.87M | 33.41M | |||
| Other non cash items | 8.26M | 8.23M | 7.30M | 10.67M | 22.86M | |||
| OPERATING CASH FLOW | -59.79M | -55.03M | -47.43M | -50.83M | -15.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.14M | -642.00K | -3.26M | -6.30M | -1.72M | |||
| Other Investing Activity | -119.14M | -119.82M | -22.72M | 0.00 | N/A | |||
| INVESTING CASH FLOW | -120.27M | -120.46M | -25.98M | -6.30M | -1.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -149.00K | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | N/A | 166.56M | -2.00K | 327.00K | 154.79M | |||
| Other Financing Activity | N/A | -4.18M | 24.39M | -1.59M | -2.03M | |||
| FINANCING CASH FLOW | N/A | 162.23M | 24.39M | -1.26M | 152.75M | |||
| CHANGE IN CASH | -17.60M | -13.27M | -49.01M | -58.39M | 135.73M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -59.79M | -55.03M | -47.43M | -50.83M | -15.30M | |||
| Capital Expenditure | -1.14M | -642.00K | -3.26M | -6.30M | -1.72M | |||
| FREE CASH FLOW | -60.92M | -55.67M | -50.69M | -57.13M | -17.03M | |||
All data in USD